Advertisement
Home Tags Migraine

Tag: Migraine

FDA Approves Symbravo for Acute Treatment of Migraine in Adults

0

Symbravo can rapidly eliminate migraine pain within two hours, with efficacy sustained through 24 and 48 hours, across migraine pain severity

Propranolol May Reduce Overall Stroke Risk in Women With Migraine

0

Protective effect more pronounced for ischemic stroke and in women with migraine without aura

Atogepant Superior for Efficacy, Functional Measures in Migraine

0

Reductions in weekly migraine days seen at weeks 1 to 4 and in monthly migraine days in first four weeks

Older Adults With Migraine Experienced Higher Depression Risk During Pandemic

0

Findings particularly pronounced for those experiencing pandemic-related stressors

FDA Approves Nerivio for Migraine Treatment in Children Aged 8 Years and Older

0

Device becomes the first and only remote electrical neuromodulation wearable for migraine treatment for children 8 years and older

Clinical Practice Guideline Updated for Migraine, Tension-Type Headache

0

Guidelines include 52 recommendations on evaluation, pharmacotherapy, invasive interventions, and nonpharmacologic interventions

Study Addresses Differentiating Meniere Disease, Vestibular Migraine

0

Dissociation between pathological caloric testing, normal video head impulse test can differentiate Meniere disease from vestibular migraine

Review Compares Drug Interventions for Acute Migraine Treatment

0

Eletriptan most effective for pain freedom at two hours in head-to-head comparisons, followed by rizatriptan, sumatriptan, and zolmitriptan

Erenumab Effective for Nonopioid Medication Overuse Headache in Chronic Migraine

0

Safety profile similar to other trials, with six in 10 sustaining medication overuse headache remission over six months

Monoclonal Antibody Tops Placebo for Reducing Migraine Frequency

0

Humanized mAb directed against pituitary adenylate cyclase-activating polypeptide ligand reduces migraines over four weeks